REFERENCES
- Jaeken J, Péanne R. What is new in CDG? J Inherit Metab Dis. 2017;
40:569-586.
- Altassan R, Witters P, Saifudeen Z, et al. Renal involvement in
PMM2-CDG, a mini-review. Mol Genet Metab. 2018;123:292-296.
- Wang CS, Greenbaum LA. Nephrotic syndrome. Pediatr Clin North Am.
2019;66:73-85.
- Hutchesson ACJ, Gray RGF, Spencer DA, Keir G. Carbohydrate deficient
glycoprotein syndrome; multiple abnormalities and diagnostic delay.
Arch Dis Child. 1995; 72: 445-446.
- van der Knaap MS, Wevers RA, Monnens L, Jakobs C, Jaeken J, van Wijk
JAE. Congenital nephrotic syndrome: a novel phenotype of type I
carbohydrate-deficient glycoprotein syndrome.J Inherit Metab Dis.
1996;19:787-791.
- Jamroz E, Adamek D, Paprocka J, Adamowicz M, Marszal E, Wevers RA. CDG
type Ia and congenital cytomegalovirus infection: two coexisting
conditions. J Child Neurol. 2009;24:13-18.
- Schiff M, Roda C, Monin M-L, et al. Clinical, laboratory and molecular
findings and long-term follow-up data in 96 French patients with
PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation)
and review of the literature. J Med Genet. 2017;54:843-851.
- Jaeken J, Stibler H, Hagberg B. Clinical presentation and natural
course of the carbohydrate-deficient glycoprotein syndrome. Acta
Paediatr Scand. 1991; Suppl.
375:6-13.